Ryanodex

EGL-4104 · Eagle Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Ryanodex, covering 2017-05-09 to 2021-04-26. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of Ryanodex as Adjuvant Treatment in Subjects With EHS [Phase 3]